{
    "clinical_study": {
        "@rank": "92415", 
        "acronym": "NKG2D", 
        "biospec_descr": {
            "textblock": "blood/serum"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "This is an observational multi-center study to determine whether any single immune\n      monitoring test or a combination of tests obtained in the first 6 months after renal\n      transplantation correlates with acute rejection or graft loss in renal allograft recipients\n      receiving commonly used immunosuppressive."
        }, 
        "brief_title": "Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Kidney Transplant", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  human kidney transplant recipients\n\n          -  ATG or basiliximab induction therapy\n\n        Exclusion Criteria:\n\n          -  induction therapy other than ATG or basiliximab"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Cohort of 80 living and deceased donor kidney transplant recipients and 10 healthy\n        volunteers"
            }
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914354", 
            "org_study_id": "859869783"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "T cells", 
            "Human Alloimmune Reactivity", 
            "immunosuppression"
        ], 
        "lastchanged_date": "August 1, 2013", 
        "number_of_groups": "1", 
        "official_title": "Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity: An Untargeted T Cell Population\" (# 859869783).", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "To document the prevalence and frequencies of CD4+ and CD8+ CD28null/NKG2Dpos T cells at the time of transplantation.", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "To test whether CD28null/NKG2Dpos T cells have unique rapid activation properties to allogeneic HLA antigens in vitro", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914354"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "To study the clinical correlations between the frequencies of alloreactive CD28null/NKG2Dpos T cells with kidney graft function and histopathology.", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "To test the effects of induction therapy with rabbit anti-thymocyte globulin (ATG) vs. IL-2 receptor blocker antibodies on circulating CD28null/NKG2Dpos T cells.", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "The Cleveland Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Cleveland Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Observational Model: Case Control", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}